PATENT CLAIM ANALYSIS

Application Number: 16329399
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-07
Patent Classification: ["514", "092000"]

Abstract:
Disclosed are compounds of Formula (I), Formula (II), Formula (III), and Formula (IV) or salts thereof, wherein R 2  is —OH or —OP(O)(OH) 2 ; and R 1  is defined herein. Also disclosed are methods of using such compounds as selective agonists for G protein coupled receptor S1P 1 , and pharmaceutical compositions comprising such compounds. These compounds are useful in treating, preventing, or slowing the progression of diseases or disorders in a variety of therapeutic areas, such as autoimmune diseases and vascular disease.

Claim (Index 7):
The compound according to  claim 3  wherein said compound is (3-amino-3-(hydroxymethyl)pyrrolidin-1-yl)(2-(3-phenyl-4-(trifluoromethyl)isoxazol-5-yl)-4,5-dihydronaphtho[2,1-d]thiazol-7-yl)methanone (49 and 50); or (3-amino-3-(hydroxymethyl)pyrrolidin-1-yl)(2-(3-phenyl-4-(trifluoromethyl)isoxazol-5-yl)-4,5-dihydronaphtho[2,1-d]thiazol-7-yl)methanone (51 to 53).

Metadata:
- Claim Count in Document: 3.0
- Percentile: 99.0
- Lexical Diversity: 1.71429
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13504541', '13811032', '13883358', '13145730', '15337843']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8031052647442701
- 35 USC 102 Novelty (BERT): 0.5813928457671611
- Combined Prediction Score: 0.7809340228465592
- Mean Citation Score: 364.75398
- Max Citation Score: 498.36066
- Similarity Product: 408.989706566906

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test